Showing 1 - 8 results of 8 for search 'Bluma G. Brenner', query time: 0.03s Refine Results
  1. 1
    Phylogenetic Insights on Patterns of HIV-1 Spread and the Design of Epidemic Control Measures

    Phylogenetic Insights on Patterns of HIV-1 Spread and the Design of Epidemic Control Measures by Bluma G. Brenner

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs

    Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs by Bluma G. Brenner, Mark A. Wainberg

    Published 2010-11-01
    Get full text
    Article
  3. 3
    Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings

    Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings by Bluma G. Brenner, Ruxandra-Ilinca Ibanescu, Isabelle Hardy, Michel Roger

    Published 2017-12-01
    Get full text
    Article
  4. 4
    A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1.

    A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1. by Dimitrios Coutsinos, Cédric F Invernizzi, Daniela Moisi, Maureen Oliveira, Jorge L Martinez-Cajas, Bluma G Brenner, Mark A Wainberg

    Published 2011-01-01
    Get full text
    Article
  5. 5
    HIV-1 Genetic Diversity in Antenatal Cohort, Canada

    HIV-1 Genetic Diversity in Antenatal Cohort, Canada by Bertine S. Akouamba, Janique Viel, Hugues Charest, Natacha Merindol, Johanne Samson, Normand Lapointe, Bluma G. Brenner, Richard Lalonde, P. Richard Harrigan, Marc Boucher, Hugo Soudeyns

    Published 2005-08-01
    Get full text
    Article
  6. 6
    Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

    Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir by Maureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, Thibault Mésplède, Jean-Pierre Routy, Marjorie A. Robbins, Bluma G. Brenner, the Montreal Primary HIV (PHI) Cohort Study Group

    Published 2018-08-01
    Get full text
    Article
  7. 7
    Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022

    Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022 by Bluma G. Brenner, Ruxandra-Ilinca Ibanescu, Maureen Oliveira, Guillaume Margaillan, Bertrand Lebouché, Réjean Thomas, Jean Guy Baril, René-Pierre Lorgeoux, Michel Roger, Jean-Pierre Routy, the Montreal Primary HIV Infection (PHI) Cohort Study Group

    Published 2024-07-01
    Get full text
    Article
  8. 8
    The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002–2020)

    The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002–2020) by Bluma G. Brenner, Ruxandra-Ilinca Ibanescu, Nathan Osman, Ernesto Cuadra-Foy, Maureen Oliveira, Antoine Chaillon, David Stephens, Isabelle Hardy, Jean-Pierre Routy, Réjean Thomas, Jean-Guy Baril, Roger Leblanc, Cecile Tremblay, Michel Roger, The Montreal Primary HIV Infection (PHI) Cohort Study Group

    Published 2021-08-01
    Get full text
    Article

Search Tools: